2000
DOI: 10.1016/s0960-894x(00)00314-0
|View full text |Cite
|
Sign up to set email alerts
|

Antitumor promoting activities of 3-O-acyl-(−)-epigallocatechins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
29
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 26 publications
(29 citation statements)
references
References 10 publications
0
29
0
Order By: Relevance
“…As shown in Table 1, the (ϩ)-catechin derivatives 11, 5, and 6 with an acyl chain of carbon atoms C 8 -C 11 had more effect (percentage EBV-EA activationsϭ7.2, 8.8, and 10.7%, respectively) than the original (ϩ)-catechin (1) (21.6%) at 1ϫ10 3 mol ratios/TPA although they were slightly less effective than the corresponding (Ϫ)-EGC derivatives (percentage activationsϭ5.0-9.3%). 1) Furthermore, either shortening C 8 (in 5) or lengthening C 10 (in 6) led to a reduction in the inhibitory activity as in the case of 3-O-acyl-(Ϫ)-EGCs. Therefore the (ϩ)-catechin derivatives possessing an acyl chain of carbon atoms C 8 to C 11 could be substitutes for the corresponding 3-O-acyl-(Ϫ)-EGCs.…”
Section: Results and Disscussionmentioning
confidence: 98%
See 1 more Smart Citation
“…As shown in Table 1, the (ϩ)-catechin derivatives 11, 5, and 6 with an acyl chain of carbon atoms C 8 -C 11 had more effect (percentage EBV-EA activationsϭ7.2, 8.8, and 10.7%, respectively) than the original (ϩ)-catechin (1) (21.6%) at 1ϫ10 3 mol ratios/TPA although they were slightly less effective than the corresponding (Ϫ)-EGC derivatives (percentage activationsϭ5.0-9.3%). 1) Furthermore, either shortening C 8 (in 5) or lengthening C 10 (in 6) led to a reduction in the inhibitory activity as in the case of 3-O-acyl-(Ϫ)-EGCs. Therefore the (ϩ)-catechin derivatives possessing an acyl chain of carbon atoms C 8 to C 11 could be substitutes for the corresponding 3-O-acyl-(Ϫ)-EGCs.…”
Section: Results and Disscussionmentioning
confidence: 98%
“…The EGCs with the C-3 acyl chain of C 8 -C 11 carbon atoms showed marked antitumor-promoting activities both in the Epstein-Barr virus early antigen (EBV-EA) activation test and in the two-stage mouse skin carcinogenesis test were found to be especially promising candidates for cancer chemoprevention. 1,2) In the present work, we examined the inhibitory effects of 3-O-acyl derivatives of (ϩ)-catehin (1) against the activation of the EBV-EA since 1 is available at much lower price from Gambir (Asenyaku in Japanese, natural medicine, Uncaria gambir ROXB. listed in the Japanese Pharmacopoeia XIV) 5) than green tea catechins and thus could be a substitute for (Ϫ)-EGC (2) as a synthetic starting material of catechins with a 3-O-acyl group.…”
mentioning
confidence: 99%
“…Catechins and its derivatives showed various pharmacological activities viz antimutagenic (Paschka et al 1998), antioxidant (Gadow et al 1997, antibacterial (Hu et al 2001;Stapleton et al 2004;Park and Cho 2010), anticancer activities (Uesato et al 2000;Kumar et al 2015), and prevention of atherosclerosis (Miura et al 2001;Chyu et al 2004). Catechins face one of the major limitations.…”
Section: Introductionmentioning
confidence: 99%
“…4) It has been reported that several newly synthesized 3-O-acyl-(+)-catechins, as well as 3-O-acyl-(-)-epigallocatechins, inhibited the activation of the Epstein-Barr virus early antigen more strongly than catechins lacking the 3-O-acyl group. 5,6) 3-OOctanoyl-(+)-catechin was one of the most effective derivatives. The evidence suggests that modification of 3-OH group of catechins could enhance the biological functions of the original catechins.…”
Section: Introductionmentioning
confidence: 99%